Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 156.25 | 33.46 | 139.00 | 96.25 | 1.4442 | 1.5453 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 156.25 | 33.46 | 117.00 | 96.25 | 1.2156 | 1.2733 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 189.00 | 96.25 | 1.9636 | 2.1137 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 156.25 | 33.46 | 49.00 | 96.25 | 0.5091 | 0.2844 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 156.25 | 33.46 | 70.00 | 96.25 | 0.7273 | 0.6230 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 156.25 | 33.46 | 100.00 | 96.25 | 1.0390 | 1.0508 |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 156.25 | 33.46 | 86.00 | 96.25 | 0.8935 | 0.8576 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 156.25 | 33.46 | 98.00 | 96.25 | 1.0182 | 1.0238 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 156.25 | 33.46 | 124.00 | 96.25 | 1.2883 | 1.3616 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 156.25 | 33.46 | 69.00 | 96.25 | 0.7169 | 0.6077 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 156.25 | 33.46 | 119.00 | 96.25 | 1.2364 | 1.2987 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 79.00 | 96.25 | 0.8208 | 0.7570 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 3.00 | 96.25 | 0.0312 | -0.7944 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 96.25 | 0.0208 | -0.8425 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 114.00 | 96.25 | 1.1844 | 1.2348 | |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 156.25 | 33.46 | 86.00 | 96.25 | 0.8935 | 0.8576 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 156.25 | 33.46 | 132.00 | 96.25 | 1.3714 | 1.4604 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 156.25 | 33.46 | 119.00 | 96.25 | 1.2364 | 1.2987 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 156.25 | 33.46 | 126.00 | 96.25 | 1.3091 | 1.3865 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 156.25 | 33.46 | 89.00 | 96.25 | 0.9247 | 0.8999 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 156.25 | 33.46 | 149.00 | 96.25 | 1.5481 | 1.6640 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 156.25 | 33.46 | 53.00 | 96.25 | 0.5507 | 0.3522 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 61.00 | 96.25 | 0.6338 | 0.4829 | |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 156.25 | 33.46 | 77.00 | 96.25 | 0.8000 | 0.7277 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 156.25 | 33.46 | 89.00 | 96.25 | 0.9247 | 0.8999 |